Association of six-minute walk distance with subsequent lower extremity events in peripheral artery disease.


Journal

Vascular medicine (London, England)
ISSN: 1477-0377
Titre abrégé: Vasc Med
Pays: England
ID NLM: 9610930

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 28 4 2020
medline: 23 9 2020
entrez: 28 4 2020
Statut: ppublish

Résumé

The prognostic significance of the six-minute walk distance for lower extremity events in people with peripheral artery disease (PAD) is unknown. This longitudinal study assessed whether a poorer six-minute walk distance at baseline was associated with higher rates of subsequent lower extremity atherosclerotic disease events in PAD. A total of 369 patients (mean age 69.4 ± 10.0 years; mean ankle-brachial index (ABI) 0.67 ± 0.17; 31% women; 30% black individuals) from Chicago-area medical centers with PAD were enrolled. Participants underwent baseline six-minute walk testing and returned for annual study visits. Lower extremity events consisted of one or more of the following: ABI decline greater than 15% or medical record adjudicated lower extremity revascularization, critical limb ischemia, or amputation. At a mean follow-up of 33.3 months, lower extremity events occurred in 66/123 (53.7%) people in the first (worst) tertile of six-minute walk performance, 55/124 (44.4%) in the second tertile, and 56/122 (45.9%) in the third (best) tertile. After adjusting for age, sex, race, ABI, comorbidities, and other confounders, participants in the first (worst) tertile of six-minute walk distance at baseline had higher rates of lower extremity events during follow-up, compared to those in the best tertile at baseline (HR = 1.74, 95% CI 1.17-2.60,

Identifiants

pubmed: 32338582
doi: 10.1177/1358863X20901599
doi:

Types de publication

Comparative Study Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

319-327

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL083064
Pays : United States

Auteurs

Pooja Nayak (P)

University of Illinois College of Medicine at Chicago, Chicago, IL, USA.

Jack M Guralnik (JM)

Department of Epidemiology, University of Maryland, Baltimore, MD, USA.

Tamar S Polonsky (TS)

Department of Medicine, University of Chicago, Chicago, IL, USA.

Melina R Kibbe (MR)

Department of Surgery, University of North Carolina, Chapel Hill, NC, USA.

Lu Tian (L)

Department of Biomedical Science Data, Stanford University, Palo Alto, CA, USA.

Lihui Zhao (L)

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Michael H Criqui (MH)

Department of Family Medicine and Public Health University of California San Diego, La Jolla, CA, USA.

Luigi Ferrucci (L)

National Institute on Aging Division of Intramural Research, Baltimore, MD, USA.

Lingyu Li (L)

Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Dongxue Zhang (D)

Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Mary M McDermott (MM)

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH